RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19

D. Gonzalez ISLAS (Ciudad de México, Mexico), C. Sánchez-Moreno (Ciudad de México, Mexico), A. Orea-Tejeda (Ciudad de México, Mexico), M. Salgado-Fernández (Ciudad de México, Mexico), A. Hernández-López (Ciudad de México, Mexico), S. Galicia-Amor (Ciudad de México, Mexico), E. Trejo-Mellado (Ciudad de México, Mexico), J. García-Hernández (Ciudad de México, Mexico), J. Orozco-Gutiérrez (Ciudad de México, Mexico), C. Aboitiz-Rivera (Ciudad de México, Mexico)

Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Session: Best abstracts in pulmonary rehabilitation and chronic care
Session type: Oral Presentation
Number: 163

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Gonzalez ISLAS (Ciudad de México, Mexico), C. Sánchez-Moreno (Ciudad de México, Mexico), A. Orea-Tejeda (Ciudad de México, Mexico), M. Salgado-Fernández (Ciudad de México, Mexico), A. Hernández-López (Ciudad de México, Mexico), S. Galicia-Amor (Ciudad de México, Mexico), E. Trejo-Mellado (Ciudad de México, Mexico), J. García-Hernández (Ciudad de México, Mexico), J. Orozco-Gutiérrez (Ciudad de México, Mexico), C. Aboitiz-Rivera (Ciudad de México, Mexico). RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19. 163

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


SURVIVAL IN PATIENTS IN ON HOME OXYGEN-THERAPY. EVALUATION OF PROGNOSTIC FACTORS
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017


SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES.
Source: Eur Respir J 2007; 29: 614
Year: 2007


FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018


COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


RISK FACTORS FOR ISOLATION MULTIDRUG-RESISTANT PATHOGENS IN BRONCHIECTASIS EXACERBATIONS
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


MONITORING PHYSICAL ACTIVITY IN CARDIAC AND RESPIRATORY PATIENTS WITH THE ACCELEROMETER FITBIT ALTA HR®
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019

RELATIONSHIP BETWEEN SIX-MINUTE WALK DISTANCE, PULMONARY FUNCTIONS AND PATIENT CENTERED OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018

PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


ANALYSIS OF RESPIRATORY FUNCTION IN PATIENTS WITH MULTIPLE SCLEROSIS
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019


HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020

INHALED CORTICOSTEROIDS AND RISK OF OSTEOPOROSIS IN LATE-MIDDLE AGE SUBJECTS: A MULTICENTER EUROPEAN COHORT STUDY
Source: Virtual Congress 2020 – Management of chronic lung conditions
Year: 2020


CHARACTERIZATION OF VERY SEVERE SLEEP APNEAS AND ASSESSMENT OF METABOLIC RISK
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


EVALUATION OF OF SMALL AIRWAYS INFLAMMATORY PARAMETERS IN A GROUP OF ASTHMATIC PATIENTS
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017